|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Operating Expenses | |||||
| Selling and marketing expenses | |||||
| Provision for doubtful accounts | |||||
| General and administrative expenses | |||||
| Provision for credit loss against doubtful accounts | |||||
| Impairment of long-term investments | |||||
| Impairment of deposit due from a third party | |||||
| Total Operating Expenses | |||||
| Loss from Operations | |||||
| Other Income (Expenses) | |||||
| Interest expense, net | |||||
| Changes in fair value of warrant liabilities | |||||
| Changes in fair value of short-term investments | |||||
| Subsidy income | |||||
| Other expenses, net | |||||
| Total Other (Expenses) Income, Net | |||||
| Loss Before Income Taxes | |||||
| Income tax expenses | |||||
| Net Loss | |||||
| Other Comprehensive Income (Loss) | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive Loss | |||||
| Weighted average number of ordinary shares outstanding | |||||
| Weighted average number of ordinary shares outstanding, Basic (in shares) | |||||
| Weighted average number of ordinary shares outstanding, Diluted (in shares) | |||||
| Loss per share | |||||
| Loss per share, Basic (in dollar per share) | |||||
| Loss per share, Diluted (in dollar per share) | |||||
Loading...